Delivery Order SPE2DB22D2206-SPE2DB25FEZ68

Award Date 1/7/25
Potential Completion Date 1/29/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $17,165.69 award is for the delivery of OJJAARA 200 MG tablets to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,165.69 delivery order is for the supply of OJJAARA 200 MG TABLET, with a completion date of November 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $34,331.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OJJAARA 200 MG TABLET UU 30S, a prescription medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 24, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,331.38 firm fixed-price delivery order supports the procurement of OJJAARA 200 MG Tablets, with a period of performance through November 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,165.69 firm-fixed-price delivery order is for the supply of 4,566,176 units of the OJJAARA 200 MG TABLET, with a period of performance through November 13, 2024. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $17,758.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 26, 2024 and was awarded on December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,758.95 firm-fixed-price delivery order is for the supply of 4566598844 ! OJJAARA 200 MG TABLET UU 30S, with a period of performance through December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of OJJAARA 200 MG TABLET UU 30S. The contract is a Delivery Order with a Firm Fixed Price and has a ceiling value of $17,165.69. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $17,093.49 firm fixed-price delivery order (SPE2DB22D2206|SPE2DB25FEE34) placed by the Defense Logistics Agency (DLA) to supply 4566400010 OJJAARA 100 MG TABLET UU 30S. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of a specific pharmaceutical product, OJJAARA 100 MG TABLET UU 30S, with a ceiling value of $17,093.49 and a period of performance through July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEZ68
    Delivery Order

This federal contract award, with ID SPE2DB22D2206|SPE2DB25FEZ68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $17,863.71, is for the delivery of OJJAARA 150 MG TABLET UU 30S, a pharmaceutical product.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant portfolio of federal contract awards with the DLA and other agencies, primarily focused on supplying pharmaceutical and medical products to the U.S. government.

Generated 4/8/25, 9:48 AM